ADC Therapeutics SA
NYSE:ADCT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ADC Therapeutics SA
NYSE:ADCT
|
CH |
|
Xiaomi Corp
F:3CP
|
CN |
|
R
|
RH
DUS:RS1
|
US |
|
A
|
AT & S Austria Technologie & Systemtechnik AG
SWB:AUS
|
AT |
|
L
|
LVMH Moet Hennessy Louis Vuitton SE
LSE:0HAU
|
FR |
|
S
|
Stroeer SE & Co KgaA
DUS:SAX
|
DE |
|
P
|
Phillips 66
XMUN:R66
|
US |
|
H
|
Hanjaya Mandala Sampoerna Tbk PT
XMUN:HSZ
|
ID |
|
Laboratorio Reig Jofre SA
MAD:RJF
|
ES |
|
Fuyao Glass Industry Group Co Ltd
SSE:600660
|
CN |
|
V
|
Vector Group Ltd
XBER:VGR
|
US |
|
G
|
Greenrise Global Brands Inc
XBER:C4T
|
CA |
|
B
|
Barclays PLC
XBER:BCY
|
UK |
|
A
|
Analog Devices Inc
F:ANL
|
US |
|
D
|
Daikin Industries Ltd
XBER:DKI
|
JP |
|
C
|
Compass Group PLC
XETRA:XGR2
|
UK |
Wall St Price Targets
ADCT Price Targets Summary
ADC Therapeutics SA
According to Wall Street analysts, the average 1-year price target for ADCT is 4.85 USD with a low forecast of 0.51 USD and a high forecast of 10.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ADCT's stock price target?
Price Target
4.85
USD
According to Wall Street analysts, the average 1-year price target for ADCT is 4.85 USD with a low forecast of 0.51 USD and a high forecast of 10.5 USD.
What is the Revenue forecast for ADC Therapeutics SA?
Projected CAGR
38%
Over the last 7 years, the compound annual growth rate for Revenue has been 85%. The projected CAGR for the next 3 years is 38%.
What is the Gross Profit forecast for ADC Therapeutics SA?
Projected CAGR
53%
The compound annual growth rate for Gross Profit over the next 3 years is 53%.
